27701797|t|Opposite in vivo effects of agents that stimulate or inhibit the glutamate/cysteine exchanger system xc- on the inhibition of hippocampal LTP by Ass.
27701797|a|Aggregated amyloid ss-protein (Ass) is pathognomonic of Alzheimer's disease and certain assemblies of Ass are synaptotoxic. Excess glutamate or diminished glutathione reserve are both implicated in mediating or modulating Ass-induced disruption of synaptic plasticity. The system xc- antiporter promotes Na+ -independent exchange of cystine with glutamate thereby providing a major source of extracellular glutamate and intracellular glutathione concentrations. Here we probed the ability of two drugs with opposite effects on system xc-, the inhibitor sulfasalazine and facilitator N-acetylcysteine, to modulate the ability of Ass1-42 to inhibit long-term potentiation (LTP) in the CA1 area of the anaesthetized rat. Whereas acute systemic treatment with sulfasalazine lowered the threshold for Ass to interfere with synaptic plasticity, N-acetylcysteine prevented the inhibition of LTP by Ass alone or in combination with sulfasalazine. Moreover acute N-acetylcysteine also prevented the inhibition of LTP by TNFalpha, a putative mediator of Ass actions, and repeated systemic N-acetylcysteine treatment for 7 days reversed the delayed deleterious effect of Ass on LTP. Since both of these drugs are widely used clinically, further evaluation of their potential beneficial and deleterious actions in early Alzheimer's disease seems warranted.   2016 Wiley Periodicals, Inc.
27701797	145	148	Ass	Gene	25698
27701797	161	179	amyloid ss-protein	Gene	25698
27701797	181	184	Ass	Gene	25698
27701797	206	225	Alzheimer's disease	Disease	MESH:D000544
27701797	252	255	Ass	Gene	25698
27701797	281	290	glutamate	Chemical	MESH:D018698
27701797	305	316	glutathione	Chemical	MESH:D005978
27701797	372	375	Ass	Gene	25698
27701797	384	417	disruption of synaptic plasticity	Disease	MESH:D010411
27701797	483	490	cystine	Chemical	MESH:D003553
27701797	496	505	glutamate	Chemical	MESH:D018698
27701797	556	565	glutamate	Chemical	MESH:D018698
27701797	584	595	glutathione	Chemical	MESH:D005978
27701797	703	716	sulfasalazine	Chemical	MESH:D012460
27701797	733	749	N-acetylcysteine	Chemical	MESH:D000111
27701797	778	785	Ass1-42	Chemical	-
27701797	863	866	rat	Species	10116
27701797	906	919	sulfasalazine	Chemical	MESH:D012460
27701797	946	949	Ass	Gene	25698
27701797	989	1005	N-acetylcysteine	Chemical	MESH:D000111
27701797	1041	1044	Ass	Gene	25698
27701797	1074	1087	sulfasalazine	Chemical	MESH:D012460
27701797	1104	1120	N-acetylcysteine	Chemical	MESH:D000111
27701797	1161	1169	TNFalpha	Gene	24835
27701797	1194	1197	Ass	Gene	25698
27701797	1229	1245	N-acetylcysteine	Chemical	MESH:D000111
27701797	1310	1313	Ass	Gene	25698
27701797	1458	1477	Alzheimer's disease	Disease	MESH:D000544
27701797	Cotreatment	MESH:D000111	MESH:D012460
27701797	Association	MESH:D003553	MESH:D018698
27701797	Association	MESH:D005978	25698
27701797	Positive_Correlation	MESH:D018698	25698
27701797	Negative_Correlation	MESH:D005978	MESH:D010411
27701797	Negative_Correlation	MESH:D000111	25698
27701797	Positive_Correlation	MESH:D018698	MESH:D010411
27701797	Positive_Correlation	MESH:D010411	25698
27701797	Association	MESH:D003553	MESH:D005978
27701797	Association	MESH:D000544	25698
27701797	Negative_Correlation	MESH:D000111	24835
27701797	Association	24835	25698
27701797	Negative_Correlation	MESH:D012460	25698

